Gene · 6607
Papers3,510
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
501 to 520 of 3,510
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Long-term nusinersen treatment across a wide spectrum of spinal muscular atrophy severity: a real-world experience. | Orphanet J Rare Dis | 2023 | 37542300 | PubTator, text mining | PubMed |
| CARM1 arginine methyltransferase as a therapeutic target for cancer. | J Biol Chem | 2023 | 37536629 | PubTator, text mining | PubMed |
| Pre-mRNA splicing-associated diseases and therapies. | RNA Biol | 2023 | 37528617 | PubTator, text mining | PubMed |
| Phenotypic heterogeneity in human genetic diseases: ultrasensitivity-mediated threshold effects as a unifying molecular mechanism. | J Biomed Sci | 2023 | 37525275 | PubTator, text mining | PubMed |
| Editorial: Non-coding RNAs in neurodegenerative diseases. | Front Neurosci | 2023 | 37521693 | PubTator, text mining | PubMed |
| Changes in pNFH Levels in Cerebrospinal Fluid and Motor Evolution after the Loading Dose with Nusinersen in Different Types of Spinal Muscular Atrophy. | Medicina (Kaunas) | 2023 | 37512056 | PubTator, text mining | PubMed |
| The Carrier Frequency of Two SMN1 Genes in Parents of Symptomatic Children with SMA and the Significance of SMN1 Exon 8 in Carriers. | Genes (Basel) | 2023 | 37510307 | PubTator, text mining | PubMed |
| Spinal Muscular Atrophy Treatment in Patients Identified by Newborn Screening-A Systematic Review. | Genes (Basel) | 2023 | 37510282 | PubTator, text mining | PubMed |
| AAV9-mediated SMN gene therapy rescues cardiac desmin but not lamin A/C and elastin dysregulation in Smn2B/- spinal muscular atrophy mice. | Hum Mol Genet | 2023 | 37498175 | PubTator, text mining | PubMed |
| Evaluating the performance of four assays for carrier screening of spinal muscular atrophy. | Clin Chim Acta | 2023 | 37479010 | PubTator, text mining | PubMed |
| Identifying Biomarkers of Spinal Muscular Atrophy for Further Development. | J Neuromuscul Dis | 2023 | 37458045 | PubTator, text mining | PubMed |
| Gene-repaired iPS cells as novel approach for patient with osteogenesis imperfecta. | Front Bioeng Biotechnol | 2023 | 37456734 | PubTator, text mining | PubMed |
| MTG-Link: leveraging barcode information from linked-reads to assemble specific loci. | BMC Bioinformatics | 2023 | 37452278 | PubTator, text mining | PubMed |
| Recent advances in RNA-targeting therapy for neurological diseases. | Neural Regen Res | 2023 | 37449612 | PubTator, text mining | PubMed |
| New Efforts to Demonstrate the Successful Use of TRH as a Therapeutic Agent. | Int J Mol Sci | 2023 | 37446225 | PubTator, text mining | PubMed |
| A framework for individualized splice-switching oligonucleotide therapy. | Nature | 2023 | 37438524 | PubTator, text mining | PubMed |
| How is Physical Activity Measured in Spinal Muscular Atrophy and Duchenne Muscular Dystrophy? | J Neuromuscul Dis | 2023 | 37424475 | PubTator, text mining | PubMed |
| Closing the Gap - Detection of 5q-Spinal Muscular Atrophy by Short-Read Next-Generation Sequencing and Unexpected Results in a Diagnostic Patient Cohort. | J Neuromuscul Dis | 2023 | 37424474 | PubTator, text mining | PubMed |
| Continued benefit of nusinersen initiated in the presymptomatic stage of spinal muscular atrophy: 5-year update of the NURTURE study. | Muscle Nerve | 2023 | 37409780 | PubTator, text mining | PubMed |
| A protospacer adjacent motif-free, multiplexed, and quantitative nucleic acid detection platform with barcode-based Cas12a activity. | MedComm (2020) | 2023 | 37405277 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6607/papers?page=26